J1.1 cells were treated with Z-VAD-FMK, necrostatin-1s, or a combination of both for 1 h prior to SMAC mimetic treatment only, MG1 infection only, or concurrent treatment with a SMAC mimetic and MG1. This evidence concerns the gene MUC5B and infection.